Antinuclear antibody pattern and autoantibody profiling of systemic sclerosis patients in a tertiary referral center in North India

• DOI: 10.1111/pin.13221
• Publication Date: 2022-03-23T13:09:12Z
• Authors: Sanghamitra Machhua; Shefali K. Sharma; Yashwant Kumar; Shashi Anand; Sanjeev Handa; Ranjana W. Minz
• Keywords: Adult; Tertiary Care Centers; 03 medical and health sciences; Scleroderma, Systemic; 0302 clinical medicine; Antibodies, Antinuclear; Humans; RNA Polymerase III; Autoantibodies; 3. Good health

AbstractAntinuclear antibody (ANA) pattern and autoantibody (autoAb) profiling of 150 adult systemic sclerosis (SSc) patients concerning their clinical association and diagnostic significance were analyzed by indirect immunofluorescence (IIF), immunoblot, and fluorescence enzyme immunoassay. One hundred and forty‐three (95.3%) patients had positive ANA: DNA topoisomerase I (topo I)‐like pattern‐84(56%); speckled pattern‐44(29.3%);centromere pattern‐7(4.6%); and nucleolar pattern‐4(2.6%). Three distinct topo I‐like immunofluorescence patterns were detected at 1:40 dilution. Topo I‐like pattern (32/75–limited cutaneous systemic sclerosis (lcSSc) vs. 52/75‐diffuse cutaneous systemic sclerosis (dcSSc); p < 0.001) was found to be associated with dcSSc subset and speckled pattern (lcSSc 28/75 vs. dcSSc 16/75; p < 0.03) with lcSSc subset. One hundred and thirty‐eight (92%) patients were positive for SSc‐associated autoAbs. The frequency distribution of autoAbs to topo I, centromere A (CENP A) and centromereB (CENP B), RNA polymerase III (RP11, RP155), fibrillarin (U3RNP), nucleolus organizer region (NOR)‐90, Th/To, PM‐Scl75, PM‐Scl100, Ku, platelet‐derived growth factor receptor (PDGFR) and Ro‐52, were 87(58%), 9(6%), 8(5.3%), 6(4%), 9(6%), 0, 6(4%), 6(4%), 8(5.3%), 5(3.3%), 11(7.3%),0 and 46(30.6%), respectively. Topo I autoAb was strongly associated with dcSSc (35/75 lcSSc vs. 52/75 dcSSc; p < 0.004), Raynaud's (p < 0.003), interstitial lung disease (ILD) (p < 0.001) and pulmonary arterial hypertension (PAH) (p < 0.04). This study helps in defining SSc clinical subset, prognostic markers of disease severity, characterization of the topo I‐like ANA pattern, and provides a definite association between the ANA patterns and corresponding autoAb.